Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tingchang Biotech is a biopharmaceutical company based in Shanghai, China, specializing in the development of advanced cell culture platforms for vaccine and biologics production. The company utilizes its proprietary ST-Cell high-density suspension culture technology and serum-free media to optimize manufacturing efficiency and product quality. Tingchang's business model includes both an internal product pipeline and comprehensive CDMO services for global partners. Its human health pipeline features candidates for rabies and human papillomavirus (HPV), while its veterinary division offers several commercialized vaccines for livestock. The company has secured significant venture capital funding to expand its manufacturing capabilities and accelerate clinical trials. By focusing on technological innovation in upstream processing, Tingchang aims to make high-quality biologics more accessible and affordable.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ting Chang.